Free Trial

Balchem (NASDAQ:BCPC) Stock Price Down 84.7% - Here's Why

Balchem logo with Basic Materials background

Balchem Corporation (NASDAQ:BCPC - Get Free Report)'s share price traded down 84.7% during trading on Monday . The stock traded as low as $158.32 and last traded at $24.29. 3,732 shares traded hands during mid-day trading, a decline of 97% from the average session volume of 142,255 shares. The stock had previously closed at $158.35.

Wall Street Analysts Forecast Growth

BCPC has been the topic of several recent research reports. HC Wainwright set a $180.00 price objective on shares of Balchem and gave the stock a "buy" rating in a research note on Monday, April 28th. Wall Street Zen downgraded Balchem from a "buy" rating to a "hold" rating in a research report on Wednesday, May 21st.

Read Our Latest Report on Balchem

Balchem Trading Up 1.6%

The company has a current ratio of 2.44, a quick ratio of 1.40 and a debt-to-equity ratio of 0.18. The stock has a market cap of $5.28 billion, a price-to-earnings ratio of 38.93, a P/E/G ratio of 3.42 and a beta of 0.91. The company has a fifty day simple moving average of $162.77 and a 200-day simple moving average of $163.22.

Balchem (NASDAQ:BCPC - Get Free Report) last released its quarterly earnings results on Thursday, April 24th. The basic materials company reported $1.22 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.25 by ($0.03). The firm had revenue of $250.52 million for the quarter, compared to analyst estimates of $245.70 million. Balchem had a net margin of 14.16% and a return on equity of 12.01%. The firm's revenue was up 4.5% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.03 EPS. On average, research analysts forecast that Balchem Corporation will post 4.64 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Balchem

A number of institutional investors have recently bought and sold shares of the business. Compound Planning Inc. lifted its position in shares of Balchem by 4.1% in the first quarter. Compound Planning Inc. now owns 1,789 shares of the basic materials company's stock worth $297,000 after purchasing an additional 70 shares in the last quarter. Quadrant Capital Group LLC increased its stake in Balchem by 8.2% in the 4th quarter. Quadrant Capital Group LLC now owns 989 shares of the basic materials company's stock valued at $161,000 after buying an additional 75 shares during the period. Covestor Ltd lifted its position in Balchem by 93.8% in the 4th quarter. Covestor Ltd now owns 157 shares of the basic materials company's stock worth $26,000 after buying an additional 76 shares in the last quarter. Arizona State Retirement System boosted its stake in shares of Balchem by 0.8% during the 4th quarter. Arizona State Retirement System now owns 9,413 shares of the basic materials company's stock valued at $1,534,000 after buying an additional 77 shares during the period. Finally, Vident Advisory LLC grew its holdings in shares of Balchem by 6.0% during the 4th quarter. Vident Advisory LLC now owns 1,421 shares of the basic materials company's stock valued at $232,000 after acquiring an additional 80 shares in the last quarter. 87.91% of the stock is currently owned by institutional investors and hedge funds.

About Balchem

(Get Free Report)

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.

Recommended Stories

Should You Invest $1,000 in Balchem Right Now?

Before you consider Balchem, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Balchem wasn't on the list.

While Balchem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Stocks to BUY NOW in July 2025
3 Defense Stocks Under $10 With Massive Upside
NVIDIA: Another 200% Growth Ahead? (PLUS 2 Companies Riding Along)

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines